148
Views
62
CrossRef citations to date
0
Altmetric
Research Article

A double-blind, comparative, placebo-controlled study of the efficacy and tolerability of 4% hydroquinone as a depigmenting agent in melasma

, &
Pages 173-179 | Published online: 12 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Sophia Hu, Melissa R. Laughter, Jaclyn B. Anderson & Mona Sadeghpour. (2022) Emerging topical therapies to treat pigmentary disorders: an evidence-based approach. Journal of Dermatological Treatment 33:4, pages 1931-1937.
Read now
Jaime Piquero-Casals, Corinne Granger, Vanesa Piquero-Casals, Aurora Garre & Juan Francisco Mir-Bonafé. (2020) A Treatment Combination of Peels, Oral Antioxidants, and Topical Therapy for Refractory Melasma: A Report of 4 Cases. Clinical, Cosmetic and Investigational Dermatology 13, pages 209-213.
Read now
Essam-Elden Mohamed Mohamed, Abdel-Khalek Hassan Younes & Ghada Mohamed Hussein. (2020) Efficacy of 577 nm pro-yellow laser in the treatment of melasma: a prospective split-face study. Journal of Cosmetic and Laser Therapy 22:2, pages 107-110.
Read now
Enzo Berardesca, Marco Ardigò, Marta Berardesca & Norma Cameli. (2008) Melasma: current and future treatments. Expert Review of Dermatology 3:2, pages 187-193.
Read now

Articles from other publishers (58)

Katherine Berry, Katherine Hallock & Charlene Lam. (2023) Photoaging and Topical Rejuvenation. Clinics in Plastic Surgery 50:3, pages 381-390.
Crossref
Dayoung Ko, Rebecca F. Wang, David Ozog, Henry W. Lim & Tasneem F. Mohammad. (2023) Disorders of hyperpigmentation. Part II. Review of management and treatment options for hyperpigmentation. Journal of the American Academy of Dermatology 88:2, pages 291-320.
Crossref
Nimra Khan, Sofia Ahmed, Muhammad Ali Sheraz, Zubair Anwar & Iqbal Ahmad. 2023. 167 210 .
Woraphong Manuskiatti, Chadakan Yan, Ma. Christina Banate Gulfan, Thanya Techapichetvanich & Rungsima Wanitphakdeedecha. (2022) Combination of a 755‐nm picosecond laser and hydroquinone 2% cream versus hydroquinone 2% cream alone for the treatment of melasma: A randomized, split‐face, and controlled trial. Lasers in Surgery and Medicine 54:10, pages 1245-1250.
Crossref
Zuzanna Piętowska, Danuta Nowicka & Jacek C. Szepietowski. (2022) Understanding Melasma-How Can Pharmacology and Cosmetology Procedures and Prevention Help to Achieve Optimal Treatment Results? A Narrative Review. International Journal of Environmental Research and Public Health 19:19, pages 12084.
Crossref
Vikram K. Mahajan, Anant Patil, Leszek Blicharz, Martin Kassir, Nellie Konnikov, Michael H. Gold, Mitchel P. Goldman, Hassan Galadari & Mohamad Goldust. (2022) Medical therapies for melasma. Journal of Cosmetic Dermatology 21:9, pages 3707-3728.
Crossref
Katherine Berry, Katherine Hallock & Charlene Lam. (2022) Photoaging and Topical Rejuvenation. Facial Plastic Surgery Clinics of North America 30:3, pages 291-300.
Crossref
Mason Jarius Tangau, Yie Kie Chong & Keng Yoon Yeong. (2022) Advances in cosmeceutical nanotechnology for hyperpigmentation treatment. Journal of Nanoparticle Research 24:8.
Crossref
Kourtney Pony & Kiyanna Williams. (2022) A Multimodal Approach to Melasma. Advances in Cosmetic Surgery 5:1, pages 1-8.
Crossref
Kanika Kamal, Kerry Heitmiller & Mitalee Christman. (2022) Lasers, lights, and compounds for melasma in aesthetics. Clinics in Dermatology 40:3, pages 249-255.
Crossref
Chingshubam BikashRashmi SarkarVineet RelhanSarika Singh. (2022) Role of Platelet-Rich Plasma Therapy as an Adjuvant in Treatment of Melasma. Dermatologic Surgery 48:4, pages 429-434.
Crossref
J. Yoo. (2021) Differential diagnosis and management of hyperpigmentation. Clinical and Experimental Dermatology 47:2, pages 251-258.
Crossref
T. Searle, F. Al‐Niaimi & F. R. Ali. (2020) Hydroquinone: myths and reality. Clinical and Experimental Dermatology 46:4, pages 636-640.
Crossref
Jennifer Nguyen, Laura Remyn, In Young Chung, Anthony Honigman, Shima Gourani‐Tehrani, Ilycia Wutami, Celestine Wong, Eldho Paul & Michelle Rodrigues. (2020) Evaluation of the efficacy of cysteamine cream compared to hydroquinone in the treatment of melasma: A randomised, double‐blinded trial. Australasian Journal of Dermatology 62:1.
Crossref
Shymaa Hatem, Nada M. El Hoffy, Reham S. Elezaby, Maha Nasr, Amany O. Kamel & Seham A. Elkheshen. (2020) Background and different treatment modalities for melasma: Conventional and nanotechnology-based approaches. Journal of Drug Delivery Science and Technology 60, pages 101984.
Crossref
Nahla Shihab, Joedo Prihartono, Andrea Tovar‐Garza, Triana Agustin, Lili Legiawati & Amit G Pandya. (2020) Randomised, controlled, double‐blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma. Australasian Journal of Dermatology 61:3, pages 237-242.
Crossref
Sameh S. M. Soliman, Rania Hamdy, Samia A. ElseginyTeclegiorgis GebremariamAlshaimaa M. Hamoda, Mohamed Madkour, Thenmozhi Venkatachalam, Mai N. Ershaid, Mohammad G. Mohammad, Georgios Chamilos & Ashraf S. Ibrahim. (2020) Selective inhibition of Rhizopus eumelanin biosynthesis by novel natural product scaffold-based designs caused significant inhibition of fungal pathogenesis . Biochemical Journal 477:13, pages 2489-2507.
Crossref
Jacqueline McKesey, Andrea Tovar-Garza & Amit G. Pandya. (2019) Melasma Treatment: An Evidence-Based Review. American Journal of Clinical Dermatology 21:2, pages 173-225.
Crossref
Lan Feng, Nannan Shi, Shasha Cai, Xue Qiao, Peng Chu, Hui Wang, Feida Long, Huaixin Yang, Yongliang Yang, Yipeng Wang & Haining Yu. (2018) De Novo Molecular Design of a Novel Octapeptide That Inhibits In Vivo Melanogenesis and Has Great Transdermal Ability. Journal of Medicinal Chemistry 61:15, pages 6846-6857.
Crossref
Harini R. BalaSenhong LeeCelestine WongAmit.G. PandyaMichelle Rodrigues. (2018) Oral Tranexamic Acid for the Treatment of Melasma: A Review. Dermatologic Surgery 44:6, pages 814-825.
Crossref
Mona Sadeghpour, Jeffrey S. Dover & Thomas E. Rohrer. (2018) Advances in the Treatment of Melasma. Advances in Cosmetic Surgery 1:1, pages 163-174.
Crossref
Priyadarshani Galappatthy & Deepani Rathnayake. 2018. Pigmentary Skin Disorders. Pigmentary Skin Disorders 261 280 .
Young-Jun Choi, Jae-Hui Nam, Jung Yup Kim, Joon Hong Min, Kui Young Park, Eun Jung Ko, Beom Joon Kim & Won-Serk Kim. (2017) Efficacy and safety of a novel picosecond laser using combination of 1 064 and 595 nm on patients with melasma: A prospective, randomized, multicenter, split-face, 2% hydroquinone cream-controlled clinical trial. Lasers in Surgery and Medicine 49:10, pages 899-907.
Crossref
Judy Cheng & Neelam A. Vashi. 2017. Dermatoanthropology of Ethnic Skin and Hair. Dermatoanthropology of Ethnic Skin and Hair 417 436 .
Sandra Maria Barbosa Durães, Rosa Rabello Fonseca & Maria Claudia Almeida Issa. 2017. Daily Routine in Cosmetic Dermatology. Daily Routine in Cosmetic Dermatology 67 99 .
Eubee Koo, Alexandra B. Kimball & Molly Wanner. 2016. Rook's Textbook of Dermatology, Ninth Edition. Rook's Textbook of Dermatology, Ninth Edition 1 16 .
Jasmine S. McNair & Porcia B. Love. 2016. Clinical Cases in Skin of Color. Clinical Cases in Skin of Color 135 146 .
Sandra Maria Barbosa Durães, Rosa Rabello Fonseca & Maria Claudia Almeida Issa. 2016. Daily Routine in Cosmetic Dermatology. Daily Routine in Cosmetic Dermatology 1 34 .
Sini K. Radhakrishnan, Ronald G. Shimmon, Costa Conn & Anthony T. Baker. (2016) Evaluation of Novel Chalcone Oximes as Inhibitors of Tyrosinase and Melanin Formation in B16 Cells. Archiv der Pharmazie 349:1, pages 20-29.
Crossref
Sini Radhakrishnan, Ronald Shimmon, Costa Conn & Anthony Baker. (2015) Development of hydroxylated naphthylchalcones as polyphenol oxidase inhibitors: Synthesis, biochemistry and molecular docking studies. Bioorganic Chemistry 63, pages 116-122.
Crossref
Sini Radhakrishnan, Ronald Shimmon, Costa Conn & Anthony Baker. (2015) Integrated kinetic studies and computational analysis on naphthyl chalcones as mushroom tyrosinase inhibitors. Bioorganic & Medicinal Chemistry Letters 25:19, pages 4085-4091.
Crossref
Michelle Rodrigues & Amit G Pandya. (2015) Melasma: clinical diagnosis and management options. Australasian Journal of Dermatology 56:3, pages 151-163.
Crossref
Zeinab A Ibrahim, Shereen F Gheida, Gamal M El Maghraby & Zeinab E Farag. (2015) Evaluation of the efficacy and safety of combinations of hydroquinone, glycolic acid, and hyaluronic acid in the treatment of melasma. Journal of Cosmetic Dermatology 14:2, pages 113-123.
Crossref
Maria Teresa Truchuelo, Natalia Jiménez & Pedro Jaén. (2014) Assessment of the efficacy and tolerance of a new combination of retinoids and depigmenting agents in the treatment of melasma. Journal of Cosmetic Dermatology 13:4, pages 261-268.
Crossref
Jung Won Shin & Kyoung Chan Park. (2014) Current clinical use of depigmenting agents. Dermatologica Sinica 32:4, pages 205-210.
Crossref
Asad Salim, Ratna Rajaratnam & Eva Soos Domanne. 2014. Evidence‐Based Dermatology. Evidence‐Based Dermatology 470 485 .
Gurpreet Singh Jutley, Ratna Rajaratnam, James Halpern, Asad Salim & Charis Emmett. (2014) Systematic review of randomized controlled trials on interventions for melasma: An abridged Cochrane review. Journal of the American Academy of Dermatology 70:2, pages 369-373.
Crossref
Ching-Yi Lien, Ching-Yu Chen, Shih-Ting Lai & Chin-Feng Chan. (2014) Kinetics of Mushroom Tyrosinase and Melanogenesis Inhibition by N -Acetyl-pentapeptides . The Scientific World Journal 2014, pages 1-9.
Crossref
N.A. Vashi & R.V. Kundu. (2013) Facial hyperpigmentation: causes and treatment. British Journal of Dermatology 169, pages 41-56.
Crossref
Shelly Rivas & Amit G. Pandya. (2013) Treatment of Melasma with Topical Agents, Peels and Lasers: An Evidence-Based Review. American Journal of Clinical Dermatology 14:5, pages 359-376.
Crossref
Tsz Wah Tse & Edith Hui. (2013) Tranexamic acid: an important adjuvant in the treatment of melasma. Journal of Cosmetic Dermatology 12:1, pages 57-66.
Crossref
So Yeon Paek & Amit G. Pandya. 2013. Skin of Color. Skin of Color 139 160 .
Anan Abu Ubeid, Sylvia Do, Chris Nye & Basil M. Hantash. (2012) Potent low toxicity inhibition of human melanogenesis by novel indole-containing octapeptides. Biochimica et Biophysica Acta (BBA) - General Subjects 1820:10, pages 1481-1489.
Crossref
Vaneeta M. Sheth & Amit G. Pandya. (2011) Melasma: A comprehensive update. Journal of the American Academy of Dermatology 65:4, pages 699-714.
Crossref
Ilaria Ghersetich, Andrea Bassi, Silvia Betti, Piero Campolmi & Torello Lotti. (2011) Treatment options for melasma: an update. Prime 1:3, pages 16-27.
Crossref
Alain Taïeb, Muriel Cario‐André, Stefania Briganti & Mauro Picardo. 2011. Melanins and Melanosomes. Melanins and Melanosomes 117 165 .
Evangeline B. Handog & Maria Juliet E. Macarayo. 2012. Color Atlas of Chemical Peels. Color Atlas of Chemical Peels 123 139 .
Sreedevi Kodali, Ian L. Guevara, Christina R. Carrigan, Seema Daulat, Gabriela Blanco, Andreas Boker, Linda S. Hynan & Amit G. Pandya. (2010) A prospective, randomized, split-face, controlled trial of salicylic acid peels in the treatment of melasma in Latin American women. Journal of the American Academy of Dermatology 63:6, pages 1030-1035.
Crossref
Ratna Rajaratnam, James Halpern, Asad Salim & Charis Emmett. (2010) Interventions for melasma. Cochrane Database of Systematic Reviews.
Crossref
Anan Abu Ubeid, Longmei Zhao, Ying Wang & Basil M. Hantash. (2009) Short-Sequence Oligopeptides with Inhibitory Activity against Mushroom and Human Tyrosinase. Journal of Investigative Dermatology 129:9, pages 2242-2249.
Crossref
T Cestari, I Arellano, D Hexsel & JP Ortonne. (2009) Melasma in Latin America: options for therapy and treatment algorithm. Journal of the European Academy of Dermatology and Venereology 23:7, pages 760-772.
Crossref
Ilgen ERTAM, Basak MUTLU, Idil UNAL, Sibel ALPER, Bijen KIVÇAK & Ozgen OZER. (2008) Efficiency of ellagic acid and arbutin in melasma: A randomized, prospective, open-label study. The Journal of Dermatology 35:9, pages 570-574.
Crossref
L. W. Draijer, H. Folmer & M. M. Verduijn. (2008) NHG-Farmacotherapeutische richtlijn Melasma/chloasma. Huisarts en Wetenschap 51:9, pages 447-450.
Crossref
Francesca Prignano, Jean-Paul Ortonne, Gionata Buggiani & Torello Lotti. (2007) Therapeutical Approaches in Melasma. Dermatologic Clinics 25:3, pages 337-342.
Crossref
A. Khemis, A. Kaiafa, C. Queille-Roussel, L. Duteil & J.P. Ortonne. (2007) Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial. British Journal of Dermatology 156:5, pages 997-1004.
Crossref
Francisco Solano, Stefania Briganti, Mauro Picardo & Ghanem Ghanem. (2006) Hypopigmenting agents: an updated review on biological, chemical and clinical aspects. Pigment Cell Research 19:6, pages 550-571.
Crossref
D. Hexsel, I. Arellano & M. Rendon. (2006) Ethnic considerations in the treatment of Hispanic and Latin-American patients with hyperpigmentation. British Journal of Dermatology 156:s1, pages 7-12.
Crossref
Marta Rendon, Mark Berneburg, Ivonne Arellano & Mauro Picardo. (2006) Treatment of melasma. Journal of the American Academy of Dermatology 54:5, pages S272-S281.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.